More cost cuts sought from drug industry
New York Times, July 23, 2009
The pharmaceutical industry has remained relatively unscathed so far in Washington?s effort to overhaul the nation's healthcare system. But despite the much publicized 10-year, $80 billion cost-saving promise the drug industry made to President Obama and the chairman of the Senate Finance Committee, some House leaders do not think the drug makers have given enough. President Obama seemed to agree during a nationally televised news conference focused on healthcare reform. He praised the pharmaceutical industry for making a hard commitment, but added "we might be able to get $100 billion out of them, or more."
Most Viewed
Most Emailed
- Primary Care Docs Average More Hospital Revenue Than Specialists
- 69% of Employers Plan to Offer Healthcare Coverage After 2014
- How Chargemaster Data May Affect Hospital Revenue
- Building a Better Healthcare Board
- Q&A: Catholic Health Initiatives' New Senior VP for Capital Finance
- ED Physicians Key to Half of Hospital Admissions
- Hospital Pricing Irks Nurses; More Jobs, Less Pay
- Insurer's App Aims to Lower Healthcare Costs, Securely
- CMS Seeks to 'Rapidly Reduce' Medicare Spending with $1B in Grants
- Quiet ORs Better for Patient Safety
